AAAAAA

   
Results: 1-10 |
Results: 10
THE ESTROGEN-RECEPTOR VARIANT LACKING EXON-5 HAS DOMINANT-NEGATIVE ACTIVITY IN THE HUMAN BREAST EPITHELIAL-CELL LINE HMT-3522S1
Authors: OHLSSON H LYKKESFELDT AE MADSEN MW BRIAND P
Citation: H. Ohlsson et al., THE ESTROGEN-RECEPTOR VARIANT LACKING EXON-5 HAS DOMINANT-NEGATIVE ACTIVITY IN THE HUMAN BREAST EPITHELIAL-CELL LINE HMT-3522S1, Cancer research, 58(19), 1998, pp. 4264-4268
RESISTANCE OF HUMAN BREAST-CANCER CELLS TO THE PURE STEROIDAL ANTIESTROGEN ICI-182,780 IS NOT ASSOCIATED WITH A GENERAL LOSS OF ESTROGEN-RECEPTOR EXPRESSION OR LACK OF ESTROGEN RESPONSIVENESS
Authors: LARSEN SS MADSEN MW JENSEN BL LYKKESFELDT AE
Citation: Ss. Larsen et al., RESISTANCE OF HUMAN BREAST-CANCER CELLS TO THE PURE STEROIDAL ANTIESTROGEN ICI-182,780 IS NOT ASSOCIATED WITH A GENERAL LOSS OF ESTROGEN-RECEPTOR EXPRESSION OR LACK OF ESTROGEN RESPONSIVENESS, International journal of cancer, 72(6), 1997, pp. 1129-1136
ESTROGEN-RECEPTOR MESSENGER-RNA SPLICE VARIANTS ARE NOT INVOLVED IN ANTIESTROGEN RESISTANCE IN SUBLINES OF MCF-7 HUMAN BREAST-CANCER CELLS
Authors: MADSEN MW REITER BE LARSEN SS BRIAND P LYKKESFELDT AE
Citation: Mw. Madsen et al., ESTROGEN-RECEPTOR MESSENGER-RNA SPLICE VARIANTS ARE NOT INVOLVED IN ANTIESTROGEN RESISTANCE IN SUBLINES OF MCF-7 HUMAN BREAST-CANCER CELLS, Cancer research, 57(4), 1997, pp. 585-589
MECHANISMS OF TAMOXIFEN RESISTANCE IN THE TREATMENT OF ADVANCED BREAST-CANCER
Authors: LYKKESFELDT AE
Citation: Ae. Lykkesfeldt, MECHANISMS OF TAMOXIFEN RESISTANCE IN THE TREATMENT OF ADVANCED BREAST-CANCER, Acta oncologica, 35(5), 1996, pp. 9-14
EFFECT OF MTS1 (S100A4) EXPRESSION ON THE PROGRESSION OF HUMAN BREAST-CANCER CELLS
Authors: GRIGORIAN M AMBARTSUMIAN N LYKKESFELDT AE BASTHOLM L ELLING F GEORGIEV G LUKANIDIN E
Citation: M. Grigorian et al., EFFECT OF MTS1 (S100A4) EXPRESSION ON THE PROGRESSION OF HUMAN BREAST-CANCER CELLS, International journal of cancer, 67(6), 1996, pp. 831-841
DIFFERENTIAL EXPRESSION OF ESTROGEN-RECEPTOR MESSENGER-RNA SPLICE VARIANTS IN THE TAMOXIFEN-RESISTANT HUMAN BREAST-CANCER CELL-LINE, MCF-7 TAM(R)-1 COMPARED TO THE PARENTAL MCF-7 CELL-LINE/
Authors: MADSEN MW REITER BE LYKKESFELDT AE
Citation: Mw. Madsen et al., DIFFERENTIAL EXPRESSION OF ESTROGEN-RECEPTOR MESSENGER-RNA SPLICE VARIANTS IN THE TAMOXIFEN-RESISTANT HUMAN BREAST-CANCER CELL-LINE, MCF-7 TAM(R)-1 COMPARED TO THE PARENTAL MCF-7 CELL-LINE/, Molecular and cellular endocrinology, 109(2), 1995, pp. 197-207
HUMAN BREAST-CANCER CELL-LINES RESISTANT TO PURE ANTIESTROGENS ARE SENSITIVE TO TAMOXIFEN TREATMENT
Authors: LYKKESFELDT AE LARSEN SS BRIAND P
Citation: Ae. Lykkesfeldt et al., HUMAN BREAST-CANCER CELL-LINES RESISTANT TO PURE ANTIESTROGENS ARE SENSITIVE TO TAMOXIFEN TREATMENT, International journal of cancer, 61(4), 1995, pp. 529-534
FLOW CYTOMETRIC DNA-PLOIDY DEFINES PATIENTS WITH POOR-PROGNOSIS IN NODE-NEGATIVE BREAST-CANCER
Authors: BALSLEV I CHRISTENSEN IJ RASMUSSEN BB LARSEN JK LYKKESFELDT AE THORPE SM ROSE C BRIAND P MOURIDSEN HT
Citation: I. Balslev et al., FLOW CYTOMETRIC DNA-PLOIDY DEFINES PATIENTS WITH POOR-PROGNOSIS IN NODE-NEGATIVE BREAST-CANCER, International journal of cancer, 56(1), 1994, pp. 16-25
ALTERED EXPRESSION OF ESTROGEN-REGULATED GENES IN A TAMOXIFEN-RESISTANT AND ICI-164,384 AND ICI-182,780 SENSITIVE HUMAN BREAST-CANCER CELL-LINE, MCF-7 TAM(R)-1/
Authors: LYKKESFELDT AE MADSEN MW BRIAND P
Citation: Ae. Lykkesfeldt et al., ALTERED EXPRESSION OF ESTROGEN-REGULATED GENES IN A TAMOXIFEN-RESISTANT AND ICI-164,384 AND ICI-182,780 SENSITIVE HUMAN BREAST-CANCER CELL-LINE, MCF-7 TAM(R)-1/, Cancer research, 54(6), 1994, pp. 1587-1595
TYPE-I IGF RECEPTOR AND ACQUIRED TAMOXIFEN RESISTANCE IN ESTROGEN-RESPONSIVE HUMAN BREAST-CANCER CELLS
Authors: WISEMAN LR JOHNSON MD WAKELING AE LYKKESFELDT AE MAY FEB WESTLEY BR
Citation: Lr. Wiseman et al., TYPE-I IGF RECEPTOR AND ACQUIRED TAMOXIFEN RESISTANCE IN ESTROGEN-RESPONSIVE HUMAN BREAST-CANCER CELLS, European journal of cancer, 29A(16), 1993, pp. 2256-2264
Risultati: 1-10 |